These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23210241)

  • 1. Development of self-microemulsifying bilayer tablets for pH-independent fast release of candesartan cilexetil.
    Sohn Y; Lee SY; Lee GH; Na YJ; Kim SY; Seong I; Lee BJ; Kuh HJ; Lee J
    Pharmazie; 2012 Nov; 67(11):917-24. PubMed ID: 23210241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
    Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
    Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate release of ibuprofen from Fujicalin®-based fast-dissolving self-emulsifying tablets.
    Kang MJ; Jung SY; Song WH; Park JS; Choi SU; Oh KT; Choi HK; Choi YW; Lee J; Lee BJ; Chi SC
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1298-305. PubMed ID: 21476949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid self-microemulsifying formulation for candesartan cilexetil.
    Nekkanti V; Karatgi P; Prabhu R; Pillai R
    AAPS PharmSciTech; 2010 Mar; 11(1):9-17. PubMed ID: 20013081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubilized formulation of olmesartan medoxomil for enhancing oral bioavailability.
    Lee BS; Kang MJ; Choi WS; Choi YB; Kim HS; Lee SK; Lee J; Choi YW
    Arch Pharm Res; 2009 Nov; 32(11):1629-35. PubMed ID: 20091278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil.
    Satturwar P; Eddine MN; Ravenelle F; Leroux JC
    Eur J Pharm Biopharm; 2007 Mar; 65(3):379-87. PubMed ID: 17123802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODS USED-FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITY AND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTAN CILEXETIL 32 MG TABLETS.
    Yuce M; Capan Y
    Acta Pol Pharm; 2017 Mar; 74(2):357-367. PubMed ID: 29624240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.
    Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A
    Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
    Shen H; Zhong M
    J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
    Surampalli G; Nanjwade BK; Patil PA; Chilla R
    Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
    Raman B; Sharma BA; Mahale G; Singh D; Kumar A
    J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems.
    Cirri M; Roghi A; Valleri M; Mura P
    Eur J Pharm Biopharm; 2016 Jul; 104():19-29. PubMed ID: 27091783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
    Ugurlu T; Nalbantoglu A; Sengel-Turk CT
    Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
    Zhang Y; Wang R; Wu J; Shen Q
    Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution media.
    Hoppe K; Sznitowska M
    AAPS PharmSciTech; 2014 Oct; 15(5):1116-25. PubMed ID: 24871550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier.
    Kim DW; Kang JH; Oh DH; Yong CS; Choi HG
    J Microencapsul; 2012; 29(4):323-30. PubMed ID: 22233141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
    Gao F; Zhang Z; Bu H; Huang Y; Gao Z; Shen J; Zhao C; Li Y
    J Control Release; 2011 Jan; 149(2):168-74. PubMed ID: 20951749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.